Daily non-political popular news in brief.

Gender impacts colorectal cancer progression

06-04-2007 · EurekAlert!

Physiological differences between men and women may contribute to differential tumor development and progression in colon cancer patients, a study led by researchers at the University of Southern California (USC) suggests.

Keywords: gender, impacts, colorectal, cancer, progression, impact

« Previous | Next »

Similar news on "Gender impacts colorectal cancer progression":

Interleukin-8, key marker for colorectal cancer treatment
10-09-2007 · EurekAlert!
Colorectal cancer constitutes one of the leading causes of cancer-related deaths worldwide. A German research group has shown that the expression of Interleukin-8, a multifunctional cytokine, correlates not only with CRC onset, but also with tumor progression and the development of colorectal liver metastases. The expression level of IL-8 might thus be a useful tool to evaluate the prognosis of patients with CRC with a high likelihood of impact on future treatment strategies.
Similar news · Read more »
Other highlights from the March 21 JNCI
03-20-2007 · EurekAlert!
Also in the March 21 JNCI are a study on the link between fat intake and breast cancer risk, a plant compound that may decrease breast cancer risk, a critique of the use of progression-free survival in cancer clinical trials, and a mutation to a mismatch repair gene that is associated with colorectal cancer.
Similar news · Read more »
Social factors not genetics drive racial disparities in colorectal cancer survival
04-23-2007 · EurekAlert!
Correcting social, economic and health-care inequalities may have the most significant impact in reducing survival differences in colorectal cancer between African-Americans and Caucasians, according to a new study.
Similar news · Read more »
Exploring better ways to determine when to change the course of treatment
06-03-2007 · EurekAlert!
Counting circulating tumor cells before and after the start of treatment for patients with metastatic colorectal cancer could help doctors determine when or if a change in treatment should be made. The results of a large, multicenter study laying the groundwork for such decisions will be presented at the annual meeting of the American Society of Clinical Oncology. The study showed the number of circulating tumor cells is a significant predictor of survival and cancer progression.
Similar news · Read more »
Cetuximab and irinotecan combination increases survival in metastatic colorectal cancer
04-16-2007 · EurekAlert!
A phase III trial of 1,298 colorectal cancer patients has found that a combination of the drugs cetuximab and irinotecan showed a significant improvement in progression-free survival over just irinotecan alone, according to an international team of researchers.
Similar news · Read more »
Rural patients' colon and lung cancers diagnosed earlier, Dartmouth research says
11-20-2007 · EurekAlert!
A new study by Dartmouth researchers suggests that urban patients with colorectal and lung cancer are more likely than their rural counterparts to "present at a late stage" -- i.e. to not be seen by a doctor until their cancers are advanced and less treatable. This effect was seen even when the study controlled for other factors associated with late-stage presentation, such as age, race, gender, marital status, income level, and level of education.
Similar news · Read more »
Colorectal cancer screening remains essential for elderly Americans
10-15-2007 · EurekAlert!
Two new studies support continued colorectal cancer screening among elderly Americans.While colorectal adenomas were detected more frequently in adults 80 and older, screening colonoscopy improved survival in the elderly by detecting colon cancer at earlier stages.
Similar news · Read more »
Low folate diets found to increase risk of colorectal cancer
11-02-2006 · EurekAlert!
A new study by scientists at the MUHC has revealed that a diet low in folate may increase the risk of developing colorectal cancer. Published in the scientific journal Cancer Research today, the study not only illustrates a way to prevent the disease but also provides further insight into the mechanisms of the disease, which could lead to novel therapies.
Similar news · Read more »
Drug that interrupts a key stage of cell division shows promise for advanced solid tumors
11-08-2006 · EurekAlert!
One of the first studies to investigate the effects of a new anti-cancer drug in patients with advanced or metastatic solid tumours has shown that it is capable of halting progression of the disease, and the study has provided the first proof of the drug's mechanism of action, the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague was told on Wednesday.
Similar news · Read more »
Tailored treatments: Promising designer drug provides new insight into cancer biology
11-13-2006 · EurekAlert!
Scientists are making progress toward unraveling the molecular mysteries that underlie cancer progression and treatment resistance. Two studies in the November 2006 issue of the journal Cancer Cell, published by Cell Press, provide mechanistic details that may explain why the small-molecule chemical ABT-737 is emerging as a unique and effective anticancer agent.
Similar news · Read more »